Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency
M Criscuolo, L Fianchi, G Dragonetti… - Expert review of …, 2016 - Taylor & Francis
Tumor lysis syndrome (TLS) is a rare but potentially life-threatening complication of
neoplasms, preferentially hematological malignancies. Well known since at least ninety …
neoplasms, preferentially hematological malignancies. Well known since at least ninety …
[HTML][HTML] Managing tumor lysis syndrome in the era of novel cancer therapies
A McBride, S Trifilio, N Baxter, TK Gregory… - Journal of the …, 2017 - ncbi.nlm.nih.gov
Tumor lysis syndrome (TLS) is a potentially life-threatening emergency that can develop
rapidly after the release of intracellular contents from lysed malignant cells. The advent of …
rapidly after the release of intracellular contents from lysed malignant cells. The advent of …
Single 6-mg dose of rasburicase: the experience in a large academic medical center
Background Tumor lysis syndrome is an oncologic emergency due to the release of tumor
cell contents, leading to metabolic derangements. Rasburicase, a recombinant urate …
cell contents, leading to metabolic derangements. Rasburicase, a recombinant urate …
The value of fixed rasburicase dosing versus weight-based dosing in the treatment and prevention of tumor lysis syndrome
A Boutin, A Blackman, DM O'Sullivan… - Journal of Oncology …, 2019 - journals.sagepub.com
Background Rasburicase is a recombinant urate oxidase enzyme used for the treatment and
prevention of tumor lysis syndrome. Our objective was to assess the efficacy of indication …
prevention of tumor lysis syndrome. Our objective was to assess the efficacy of indication …
[HTML][HTML] Hyperuricemia management
A Diaz - 2015 - jhoponline.com
Hyperuricemia Management Skip to main content JHOP Logo Home Articles Latest Issue
Issue Archive Special Issues Supplements Categories Conference Correspondent ASH 2023 …
Issue Archive Special Issues Supplements Categories Conference Correspondent ASH 2023 …
[PDF][PDF] Rasburicase Utilization After Protocol Implementation Focused on Fixed Dosing by Limiting Use of Weight-Based Dosing to Oncology Providers
D Smith BS - 2021 - researchrepository.parkviewhealth …
Rasburicase Utilization After Protocol Implementation Focused on Fixed Dosing by Limiting
Use of Weight-Based Dosing to Oncology Page 1 Parkview Health Parkview Health …
Use of Weight-Based Dosing to Oncology Page 1 Parkview Health Parkview Health …
[PDF][PDF] Manejo del síndrome de lisis tumoral en urgencias
AC Duque, LMQ Díaz - academia.edu
Abstract Tumor Lysis Syndrome is the result of a neoplastic life-threatening complication
mainly seen in hematological malignancies. Known at least 90 years ago, this condition can …
mainly seen in hematological malignancies. Known at least 90 years ago, this condition can …